New CEO commentary: “The Single-Cell Revolution”

Single-cell analysis using supercomputers

On the company’s webpage, PHI’s CEO and founder Peter Egelberg comments the recently published innovation report from the UN agency World Intellectual Property Organization. The report sets PHI’s technology area, single-cell analysis, as the cutting-edge technology that is most likely to revolutionize healthcare over the next decade — outranking high-profile innovations such as regenerative medicine, immunotherapy and gene therapy, see

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
+46 46 38 60 80

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
+1 617-963-5150


VAT: SE556542781101

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2